Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort study

Abstract

Metformin use in patients with type 2 diabetes mellitus was associated with a significantly reduced risk of total joint replacement. Randomized controlled clinical trials in patients with osteoarthritis are warranted to determine whether metformin is effective in decreasing the need for joint replacement.